Literature DB >> 24648891

Simian virus 40 enhancer does not affect the tumor specificity of human heparanase gene promoter.

Bin Chen1, Xiao-Peng Chen1, Yong Wang2, Wei Cui1, Min Zhong3.   

Abstract

The transcription activity of the tumor-specific promoter may be increased using specific DNA sequences such as simian virus 40 (SV40). Human heparanase (HPSE) gene promoter is also considered a tumor-specific promoter. However, whether or not the SV40 enhancer affects the tumor specificity of HPSE remains to be determined. The SV40 enhancer sequence, 237 bp in length, was amplified and correctly inserted into the assigned multiple clone sites (MCS) of the eukaryotic expression vector pEGFP-Hp, which was constructed in advance. The recombinant plasmid pEGFP-Hp-SV40e was consistent with the anticipated Genbank data and transfected into human umbilical vein endothelial cell (ECV) and tumor cell lines, including hepatoma carcinoma (HepG2), laryngeal carcinoma (Hep2) and chronic myelogenous leukemia cell lines (K562) using lipofectamine, respectively. The expression of the reporter gene, green fluorescent protein (GFP), was detected using fluorescence microscopy and flow cytometry. The length of the amplified SV40 enchancer was 237 bp and the sequence was in accordance with the GenBank data. The recombinant plasmid pEGFP-Hp-SV40 was consistent with the anticipated results. Fluorimetric analysis showed that the fluorescence of pEGFP-Hp-SV40e in ECV cells was as dim as pEGFP-Hp, and obviously weaker than pEGFPN1. In tumor cells including HepG2, Hep2 and K562 cells, the fluorescence of pEGFP-Hp-SV40e was similar to that of pEGFP-N1, which was clearly brighter than pEGFP-Hp. The average transfecion rates in the 4 types of cells were 4.1, 17.2, 8.8 and 6.4% in the pEGFP-Hp; 18.3, 29.3, 17.0 and 13.0% in the pEGFP-Nl and 4.3, 28.8, 16.4 and 11.7% in the pEGFP-Hp-SV40e groups, respectively. The ratio of pEGFP-Hp-SV40e to pEGFP-Hp in all cells was 1.05, 1.67, 1.86 and 1.83, respectively. In conclusion, the inserted SV40 enhancer sequence is able to improve the transcriptional activity of the human HPSE gene promoter, but does not affect its tumor specificity.

Entities:  

Keywords:  heparanase; promoter; simian virus 40 enhancer; transcription activity; tumor

Year:  2012        PMID: 24648891      PMCID: PMC3956898          DOI: 10.3892/br.2012.1

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  22 in total

1.  The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.

Authors:  O N El-Assal; A Yamanoi; T Ono; H Kohno; N Nagasue
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  Involvement of heparanase in tumor metastases: a new target in cancer therapy?

Authors:  Douglas D Boyd; Motowo Nakajima
Journal:  J Natl Cancer Inst       Date:  2004-08-18       Impact factor: 13.506

3.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

4.  Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid.

Authors:  S Li; F C MacLaughlin; J G Fewell; M Gondo; J Wang; F Nicol; D A Dean; L C Smith
Journal:  Gene Ther       Date:  2001-03       Impact factor: 5.250

5.  Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer.

Authors:  Joon-Seok Song
Journal:  Biosci Biotechnol Biochem       Date:  2005-01       Impact factor: 2.043

Review 6.  Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

Authors:  Neta Ilan; Michael Elkin; Israel Vlodavsky
Journal:  Int J Biochem Cell Biol       Date:  2006-07-06       Impact factor: 5.085

7.  Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.

Authors:  S Chapel-Fernandes; F Jordier; F Lauro; N Maitland; J Chiaroni; P de Micco; P Mannoni; C Bagnis
Journal:  Cancer Gene Ther       Date:  2006-06-02       Impact factor: 5.987

8.  Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies.

Authors:  Noriko Komatsu; Michihiko Waki; Mayumi Sue; Chikashi Tokuda; Tatsuhiko Kasaoka; Motowo Nakajima; Nobuaki Higashi; Tatsuro Irimura
Journal:  J Immunol Methods       Date:  2007-12-27       Impact factor: 2.303

9.  Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells.

Authors:  Nobuo Ishiwata; Naohiko Inase; Toshihide Fujie; Meiyo Tamaoka; Yasuyuki Yoshizawa
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

10.  Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma.

Authors:  Jian-min Yang; Hui-ju Wang; Ling Du; Xiao-mei Han; Zai-yuan Ye; Yong Fang; Hou-quan Tao; Zhong-sheng Zhao; Yong-lie Zhou
Journal:  Cancer Immunol Immunother       Date:  2009-01-25       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.